Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma

Eur J Dermatol. 2013 Jan-Feb;23(1):118. doi: 10.1684/ejd.2012.1915.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Erythema Nodosum / chemically induced*
  • Erythema Nodosum / therapy
  • Female
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Lymphatic Metastasis
  • Melanoma / drug therapy*
  • Melanoma / radiotherapy
  • Melanoma / secondary
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib